CHART-2 is Cardio3 BioSciences second Phase III trial for C-Cure, the first and only stem cell therapeutic using guided stem cells for the condition of congestive heart failure. C-Cure is currently in a Phase III clinical trial in Europe (CHART-1). The CHART-2 Phase III trial is a prospective, multi-centre, randomized, sham-controlled, patient- and evaluator-blinded study comparing treatment with C-Cure to a sham treatment. The trial is designed to recruit a minimum of 240 patients with chronic advanced symptomatic heart failure.
In a clinical trial, the Principal Investigator (PI) is responsible for the scientific and medical supervision of the trial. The PI reviews the protocol, oversees the implementation of the trial at all the investigational sites, and provides guidance as to the integrity and the interpretability of the data generated during the trial.
Dr Christian Homsy, CEO of Cardio3 BioSciences, said: Cardio3 BioSciences is very proud to count three such prominent physicians as the Co-Principal Investigators of its phase III clinical study for C-Cure authorized in the United States. The medical community is eagerly waiting for a solution for the treatment of heart failure patients, and CHART-2 is a promising avenue towards treating this disease. We selected three prominent cardiologists with established reputations and their acceptance to lead our clinical trial is further recognition of the potential of C-Cure as future treatment of heart failure.
*** END ***
To subscribe to Cardio3 BioSciences newsletter, visit http://www.c3bs.com. Follow us on Twitter @Cardio3Bio.
About CHART-2 CHART-2, the Company's second Phase III clinical trial, is intended to assess in the US, the efficacy of C-Cure as a treatment for heart failure of ischemic origin. CHART-2 is designed as a prospective, multi-centre, randomized, sham-controlled, patient- and evaluator-blinded study comparing treatment with C-Cure to a sham treatment. The trial is aimed to recruit a minimum of 240 patients with chronic advanced symptomatic heart failure. The primary endpoint of the trial is the Six Minute Walk Test post-procedure, a commonly used index of cardiovascular performance.
About C-Cure Cardio3 BioSciences C-Cure therapy involves taking stem cells from a patients own bone marrow and through a proprietary process called Cardiopoiesis, re-programming those cells to become heart cells. The cells, known as cardiopoietic cells, are then injected back into the patients heart through a minimally invasive procedure, with the aim of repairing damaged tissue and improving heart function and patient clinical outcomes. C-Cure is the outcome of multiple years of research conducted at Mayo Clinic (Rochester, Minnesota, USA), Cardio3 BioSciences (Mont-Saint-Guibert, Belgium) and Cardiovascular Centre in Aalst (Aalst, Belgium).
About Mayo Clinic Recognizing 150 years of serving humanity in 2014, Mayo Clinic is a non-profit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.150years.mayoclinic.org ; http://www.mayoclinic.org ; and http://www.newsnetwork.mayoclinic.org . Mayo Clinic has a financial interest in Cardio3 Biosciences.
About Cardio3 BioSciences Cardio3BioSciences is a Belgian leading biotechnology company focused on the discovery and development of regenerative and protective therapies for the treatment of unmet medical needs. The company was founded in 2007 and is based in the Walloon region of Belgium. Cardio3BioSciences leverages research collaborations in the US and in Europe with Mayo Clinic and the Cardiovascular Centre Aalst, Belgium. The Companys lead product candidate C-Cure is an innovative pharmaceutical product that is being developed for heart failure indication. C-Cure consists of a patients own cells that are harvested from the patients bone marrow and engineered to become new heart muscle. This process is known as Cardiopoiesis. Cardio3BioSciences has also developed C-Cathez, the most technologically advanced injection catheter with superior efficiency of delivery of bio therapeutic agents into the myocardium. Cardio3 BioSciences shares are listed on Euronext Brussels and Euronext Paris under the ticker symbol CARD.
C3BS-CQR-1, C-Cure, C-Cathez, Cardio3 BioSciences and the Cardio3 BioSciences and C-Cathezlogos are trademarks or registered trademarks of Cardio3 BioSciences SA, in Belgium, other countries, or both. Mayo Clinic holds equity in Cardio3 BioSciences as a result of intellectual property licensed to the company. In addition to historical facts or statements of current condition, this press release contains forward-looking statements, which reflect our current expectations and projections about future events, and involve certain known and unknown risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. These forward-looking statements are further qualified by important factors, which could cause actual results to differ materially from those in the forward-looking statements, including timely submission and approval of anticipated regulatory filings; the successful initiation and completion of required Phase III studies; additional clinical results validating the use of adult autologous stem cells to treat heart failure; satisfaction of regulatory and other requirements; and actions of regulatory bodies and other governmental authorities.
- Stem cells | Health Sciences - University of Minnesota [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Stem Cell FAQs - MED - Stem Cell Institute, University of ... [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Home - MED - Stem Cell Institute, University of Minnesota [Last Updated On: August 22nd, 2014] [Originally Added On: August 22nd, 2014]
- Minnesota Stem Cell Therapy | Stem Cell Treatments [Last Updated On: August 29th, 2014] [Originally Added On: August 29th, 2014]
- Researchers find animal model for understudied type of muscular dystrophy [Last Updated On: August 30th, 2014] [Originally Added On: August 30th, 2014]
- Cancer Survivor Saved by Measles Virus Raises Funds for Expanded Trial [Last Updated On: September 12th, 2014] [Originally Added On: September 12th, 2014]
- New heart built with stem cells - YouTube [Last Updated On: September 27th, 2014] [Originally Added On: September 27th, 2014]
- Becoming a blood stem cell or bone marrow donor ... [Last Updated On: October 3rd, 2014] [Originally Added On: October 3rd, 2014]
- $25M gift prompts University pediatric hospital name change [Last Updated On: October 16th, 2014] [Originally Added On: October 16th, 2014]
- Anti-Cancer Drug Effective Against Common Stem Cell Transplant Complication [Last Updated On: October 24th, 2014] [Originally Added On: October 24th, 2014]
- Mayo Clinic Researchers Identify First Steps in Formation of Pancreatic Cancer [Last Updated On: November 10th, 2014] [Originally Added On: November 10th, 2014]
- Reduction of germ cells yields more zebrafish males [Last Updated On: December 4th, 2014] [Originally Added On: December 4th, 2014]
- Stem Cell Malaysia Blog [Last Updated On: December 12th, 2014] [Originally Added On: December 12th, 2014]
- Childrens hospital gets $25M [Last Updated On: December 16th, 2014] [Originally Added On: December 16th, 2014]
- Family: Experimental stem-cell treatment does wonders for Gordie Howe [Last Updated On: December 20th, 2014] [Originally Added On: December 20th, 2014]
- Stem Cell Web Focus - Nature Publishing Group : science ... [Last Updated On: February 3rd, 2015] [Originally Added On: February 3rd, 2015]
- Jakub Tolar, M.D., Ph.D. - MED - Stem Cell Institute ... [Last Updated On: February 24th, 2015] [Originally Added On: February 24th, 2015]
- Bioelectricity Plays Key Role in Brain Development & Repair [Last Updated On: March 13th, 2015] [Originally Added On: March 13th, 2015]
- Atsushi Asakura, Ph.D. - MED - Stem Cell Institute ... [Last Updated On: March 18th, 2015] [Originally Added On: March 18th, 2015]
- Graduate Programs - MED - Stem Cell Institute, University ... [Last Updated On: April 26th, 2015] [Originally Added On: April 26th, 2015]
- Minnesota Man With ALS Hopes Stem Cells Save His Life ... [Last Updated On: July 2nd, 2015] [Originally Added On: July 2nd, 2015]
- 2. Bone Marrow (Hematopoietic) Stem Cells [Stem Cell ... [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Multipotent vs. pluripotent stem cells - Pathology Student [Last Updated On: October 19th, 2015] [Originally Added On: October 19th, 2015]
- Home - Minnesota Regenerative Medicine [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- Stem Cell Treatment - Minnesota Regenerative Medicine [Last Updated On: August 18th, 2016] [Originally Added On: August 18th, 2016]
- STEM Programs - Minnesota Zoo [Last Updated On: September 5th, 2016] [Originally Added On: September 5th, 2016]
- Minnesota to resume umbilical cord blood donations ... [Last Updated On: September 20th, 2016] [Originally Added On: September 20th, 2016]
- Minnesota invests in regenerative medicine - Health Talk [Last Updated On: October 7th, 2016] [Originally Added On: October 7th, 2016]
- Stem Cell FAQs - Minnesota Regenerative Medicine [Last Updated On: October 7th, 2016] [Originally Added On: October 7th, 2016]
- Stem cell research Experts@Minnesota [Last Updated On: October 18th, 2016] [Originally Added On: October 18th, 2016]
- Minnesotas Funding of Stem Cell Research Echoes Trend ... [Last Updated On: October 29th, 2016] [Originally Added On: October 29th, 2016]
- Stemonix, a stem cell research firm, wins Minnesota Cup ... [Last Updated On: November 27th, 2016] [Originally Added On: November 27th, 2016]
- Stem-cell clinics are using a federal website as a marketing tool for unproven treatments, U of M bioethicist says - MinnPost [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- More than 60 US clinics have sold unproven stem cell therapies for heart failure - New York Post [Last Updated On: July 30th, 2017] [Originally Added On: July 30th, 2017]
- Cargill invests in 'clean meat' start-up - KARE [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Cowboy Up Ride Against Cancer - Wahpeton Daily News [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- Mayo Clinic, University of Minnesota develop 'robocop' stem cells to fight cancer - Minneapolis Star Tribune [Last Updated On: August 24th, 2017] [Originally Added On: August 24th, 2017]
- FDA cracks down on stem cell clinics - CNN [Last Updated On: August 29th, 2017] [Originally Added On: August 29th, 2017]
- 2018 Regenerative Medicine Minnesota Research Awards [Last Updated On: August 17th, 2018] [Originally Added On: August 17th, 2018]
- The Promise of Stem Cells | Stem Cell Institute ... [Last Updated On: August 29th, 2018] [Originally Added On: August 29th, 2018]
- Stem-cell treatment gives two brothers a future ... [Last Updated On: March 3rd, 2019] [Originally Added On: March 3rd, 2019]
- Hoeven's bill supports alternative therapy for veterans with PTSD, traumatic brain injury - Ripon Advance [Last Updated On: October 1st, 2019] [Originally Added On: October 1st, 2019]
- Why Sangamo Therapeutics Stock Sank Today - The Motley Fool [Last Updated On: December 13th, 2019] [Originally Added On: December 13th, 2019]
- Coronavirus is similar to SARS and causes infection through a heart regulating enzyme: Study - International Business Times, Singapore Edition [Last Updated On: February 4th, 2020] [Originally Added On: February 4th, 2020]
- A word for those risking their lives amid the coronavirus crisis: Thanks - TwinCities.com-Pioneer Press [Last Updated On: April 4th, 2020] [Originally Added On: April 4th, 2020]
- Fate Therapeutics Announces First Patient Treated in First-in-human Clinical Trial of FT596 and Provides Corporate Update - Yahoo Finance [Last Updated On: April 4th, 2020] [Originally Added On: April 4th, 2020]
- Biotechnology Could Change the Cattle Industry. Will It Succeed? - Singularity Hub [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- University of Minnesota launches stem cell trial against severe COVID-19 - Minneapolis Star Tribune [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- University of Minnesota launches stem cell trial against ... [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- Coronavirus Thursday update: UMN announces new stem cell ... [Last Updated On: August 16th, 2020] [Originally Added On: August 16th, 2020]
- Berks County's first STEM-themed attraction opens, delights visitors young and old - Reading Eagle [Last Updated On: October 7th, 2020] [Originally Added On: October 7th, 2020]
- NMDP/Be The Match partners with M Health Fairview and Duke University cryopreservation labs to launch Be The Match BioBank - Watauga Democrat [Last Updated On: October 7th, 2020] [Originally Added On: October 7th, 2020]
- COVID-19 and the trials of treatment | News, Sports, Jobs - Escanaba Daily Press [Last Updated On: October 16th, 2020] [Originally Added On: October 16th, 2020]
- Negrin Shines Light on the Orca-T Story in GVHD - OncLive [Last Updated On: December 11th, 2020] [Originally Added On: December 11th, 2020]
- Our View: The need is vast. Consider becoming an organ donor. - PostBulletin.com [Last Updated On: August 18th, 2021] [Originally Added On: August 18th, 2021]
- EDITORIAL: The need is vast. Consider becoming an organ donor. - Yahoo News [Last Updated On: August 18th, 2021] [Originally Added On: August 18th, 2021]
- Caribou Biosciences Appoints Biotechnology Industry Veteran Ran Zheng to its Board of Directors - Stockhouse [Last Updated On: October 5th, 2021] [Originally Added On: October 5th, 2021]
- Four-year-old with rare disease finally gets historic gene therapy treatment - KARE11.com [Last Updated On: October 5th, 2021] [Originally Added On: October 5th, 2021]
- Cells or drugs? The race to regenerate the heart - Scientific American [Last Updated On: November 8th, 2021] [Originally Added On: November 8th, 2021]
- Induced Pluripotent Stem Cells and Their Potential for ... [Last Updated On: November 22nd, 2021] [Originally Added On: November 22nd, 2021]
- Minnesota woman reunites with teenager she saved through Be The Match transplant - KSTP [Last Updated On: April 19th, 2022] [Originally Added On: April 19th, 2022]
- Be the Match is looking for more ethnically diverse donors to help patients with blood cancers and diseases - KARE11.com [Last Updated On: June 4th, 2022] [Originally Added On: June 4th, 2022]
- Bluebird's future in balance as FDA weighs gene therapy approvals - BioPharma Dive [Last Updated On: June 13th, 2022] [Originally Added On: June 13th, 2022]
- Life-saving lecture: Auburn student uses lessons from class to help discover father's brain tumor - Office of Communications and Marketing [Last Updated On: June 22nd, 2022] [Originally Added On: June 22nd, 2022]
- Pluripotent stem cellderived NK cells with high-affinity noncleavable ... [Last Updated On: July 3rd, 2022] [Originally Added On: July 3rd, 2022]
- TC BioPharm Announces Formation of Scientific Advisory Board with Renowned Cell Therapy Experts - GuruFocus.com [Last Updated On: July 11th, 2022] [Originally Added On: July 11th, 2022]
- Witt Wolfpack: Family works out fundraising and awareness after La Jollan's ALS diagnosis - La Jolla Light [Last Updated On: July 11th, 2022] [Originally Added On: July 11th, 2022]
- Accelerating Transformational Research into Cell Transplantation for Patients with Type 1 Diabetes - UCSF [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- Engineers develop new tool that will allow for more personalized cell therapies - UMN News [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- University of Minnesota scientist responds to fraud allegations in Alzheimer's research - Star Tribune [Last Updated On: July 27th, 2022] [Originally Added On: July 27th, 2022]
- Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201 - Business Wire [Last Updated On: August 14th, 2022] [Originally Added On: August 14th, 2022]
- Kyle Vining: Appointment to Faculty of Penn Dental Medicine and Penn School of Engineering and Applied Science - University of Pennsylvania [Last Updated On: August 22nd, 2022] [Originally Added On: August 22nd, 2022]
- Zhang and colleagues win an $11.2 million NIH program project grant (PPG) - News - University of Alabama at Birmingham [Last Updated On: August 22nd, 2022] [Originally Added On: August 22nd, 2022]
- What Are Zombie Cells? Here's How They Impact Aging - Prevention Magazine [Last Updated On: September 8th, 2022] [Originally Added On: September 8th, 2022]
- ThreeSixty Journalism: Be The Match works to build equity in access to bone marrow and cord blood transplants - St. Paul Pioneer Press [Last Updated On: September 8th, 2022] [Originally Added On: September 8th, 2022]
- A history of blood cancer treatment - - pharmaphorum [Last Updated On: September 16th, 2022] [Originally Added On: September 16th, 2022]
- A CRISPR Alternative for Correcting Mutations That Sensitize Cells to DNA Damage - The Scientist [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- The Switch to Regenerative Medicine - Dermatology Times [Last Updated On: October 13th, 2022] [Originally Added On: October 13th, 2022]
- Stem cell treatment after spinal cord injury: The next steps - Mayo Clinic [Last Updated On: December 18th, 2022] [Originally Added On: December 18th, 2022]